These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3360593)
1. The prevalence of ouabain-resistant variants after mutagen treatment. Lack of correlation between the frequency of variant expression and the metastatic phenotype. Frost P; Kendal W; Hunt B; Ellis M Invasion Metastasis; 1988; 8(2):73-86. PubMed ID: 3360593 [TBL] [Abstract][Full Text] [Related]
2. Metastatic potential and spontaneous mutation rates: studies with two murine cell lines and their recently induced metastatic variants. Kendal WS; Frost P Cancer Res; 1986 Dec; 46(12 Pt 1):6131-5. PubMed ID: 3779633 [TBL] [Abstract][Full Text] [Related]
3. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor. Yamashina K; Heppner GH Cancer Res; 1985 Sep; 45(9):4015-9. PubMed ID: 4027998 [TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis. Lagarde AE; Donaghue TP; Dennis JW; Kerbel RS J Natl Cancer Inst; 1983 Jul; 71(1):183-91. PubMed ID: 6575202 [TBL] [Abstract][Full Text] [Related]
5. Enhanced metastatic potential of murine fibrosarcomas treated in vitro with ultraviolet radiation. Fisher MS; Cifone MA Cancer Res; 1981 Aug; 41(8):3018-23. PubMed ID: 7248958 [TBL] [Abstract][Full Text] [Related]
6. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin. Dennis JW J Natl Cancer Inst; 1985 May; 74(5):1111-20. PubMed ID: 3858579 [TBL] [Abstract][Full Text] [Related]
7. A fluctuation analysis of the rate of reexpression of the metastatic potential in a nonmetastatic mutant of the MDAY-D2 murine tumor. Lagarde AE Invasion Metastasis; 1983; 3(1):52-64. PubMed ID: 6677620 [TBL] [Abstract][Full Text] [Related]
8. Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line. Bignami M; Ficorella C; Dogliotti E; Norman RL; Kaighn ME; Saffiotti U Cancer Res; 1984 Jun; 44(6):2452-7. PubMed ID: 6722787 [TBL] [Abstract][Full Text] [Related]
9. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities. Alon Y; Hammerling GJ; Segal S; Bar-Eli M Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous fusion between metastatic mammary tumor subpopulations. Miller FR; McInerney D; Rogers C; Miller BE J Cell Biochem; 1988 Feb; 36(2):129-36. PubMed ID: 3356752 [TBL] [Abstract][Full Text] [Related]
11. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens. Altevogt P; von Hoegen P; Leidig S; Schirrmacher V Cancer Res; 1985 Sep; 45(9):4270-7. PubMed ID: 4028013 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants. Fishman D; Galitzki L; Priel E; Segal S Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768 [TBL] [Abstract][Full Text] [Related]
13. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants. Dennis JW Cancer Res; 1986 Sep; 46(9):4594-600. PubMed ID: 3755374 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of assay systems for drug-resistant mutation in cultured mammalian cells. Ochi T; Umeda M Jpn J Exp Med; 1981 Jun; 51(3):141-7. PubMed ID: 7300029 [TBL] [Abstract][Full Text] [Related]
15. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Ford HL; Salim MM; Chakravarty R; Aluiddin V; Zain SB Oncogene; 1995 Nov; 11(10):2067-75. PubMed ID: 7478526 [TBL] [Abstract][Full Text] [Related]
16. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J; Kaina B Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539 [TBL] [Abstract][Full Text] [Related]
18. Is tumor cell radiation resistance correlated with metastatic ability? Suit H; Allam A; Allalunis-Turner J; Brock W; Girinsky T; Hill S; Hunter N; Milas L; Pearcey R; Peters L Cancer Res; 1994 Apr; 54(7):1736-41. PubMed ID: 8137288 [TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor. Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]